Bill Text: MN HF284 | 2019-2020 | 91st Legislature | Engrossed

Bill Title: Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

Spectrum: Partisan Bill (Democrat 15-0)

Status: (Introduced) 2019-04-01 - Author added Bierman [HF284 Detail]

Download: Minnesota-2019-HF284-Engrossed.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.